Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

被引：5
|
作者：
Ahn, Hee Kyung [1 ]
Lee, Soohyeon [1 ]
Sun, Jong-Mu [1 ]
Lee, Jeeyun [1 ]
Park, Se Hoon [1 ]
Park, Joon Oh [1 ]
Park, Young Suk [1 ]
Kang, Won Ki [1 ]
Lim, Ho Yeong [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Seoul 135710, South Korea
来源：
INVESTIGATIONAL NEW DRUGS | 2012年 / 30卷 / 04期
关键词：
RENAL-CELL CARCINOMA; EFFICACY; PROGRESSION;
D O I：
10.1007/s10637-011-9707-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1768 / 1772
页数：5
相关论文
共 50 条
  • [21] Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma
    Hideaki Miyake
    Yuji Kusuda
    Ken-ichi Harada
    Iori Sakai
    Masato Fujisawa
    [J]. International Journal of Clinical Oncology, 2013, 18 : 81 - 86
  • [22] SUNITINIB AND SORAFENIB THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC): SAFETY PROFILE
    Massari, Francesco
    Cricca, Antonia
    Sperandi, Francesca
    Martoni, Andrea Angelo
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1379 - 1380
  • [23] Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma EDITORIAL COMMENT
    Tagawa, Scott T.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (01): : 34 - 34
  • [24] Re: Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma Reply
    不详
    [J]. JOURNAL OF UROLOGY, 2010, 183 (02): : 825 - 825
  • [25] Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma
    Hiles, Jon J.
    Kolesar, Jill M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (02) : 123 - 131
  • [26] THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    Bhojani, N.
    Jeldres, C.
    Patard, J. -J.
    Perrotte, P.
    Suardi, N.
    Hutterer, G.
    Patenaude, F.
    Oudard, S.
    Karakiewicz, P. I.
    [J]. ONKOUROLOGIYA, 2009, 5 (04): : 25 - 36
  • [27] A Cross-over Response to Sequential Use of Sunitinib after Sorafenib in a Patient with Metastatic Renal Cell Carcinoma
    Richards, T. M.
    Plowman, P. N.
    Reznek, R.
    Ball, S. A.
    [J]. CLINICAL ONCOLOGY, 2009, 21 (08) : 633 - 634
  • [28] Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study
    Loukas Kontovinis
    Konstantinos Laschos
    Alexandra Karadimou
    Charalambos Andreadis
    Aristotelis Bamias
    Panagiotis Paraskevopoulos
    Meletios Dimopoulos
    Konstantinos Papazisis
    [J]. Medical Oncology, 2012, 29 : 750 - 754
  • [29] Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study
    Kontovinis, Loukas
    Laschos, Konstantinos
    Karadimou, Alexandra
    Andreadis, Charalambos
    Bamias, Aristotelis
    Paraskevopoulos, Panagiotis
    Dimopoulos, Meletios
    Papazisis, Konstantinos
    [J]. MEDICAL ONCOLOGY, 2012, 29 (02) : 750 - 754
  • [30] Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
    Eichelberg, Christian
    Heuer, Roman
    Chun, Felix K.
    Hinrichs, Kristin
    Zacharias, Mario
    Huland, Hartwig
    Heinzer, Hans
    [J]. EUROPEAN UROLOGY, 2008, 54 (06) : 1373 - 1378
12345